HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.40−0.33 (-2.24%)
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
HUTCHMED (China) cash
Cash and short-term investments held at the end of each period.
HUTCHMED (China)'s cash was $1.37B at Jun 30, 2026. For fiscal 2025 it was $1.37B, up 63.5% from the year before. Over ten years it grew 45.6% a year on average. The highest annual figure on record is $1.37B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.37B | +63.5% |
| FY2024 | Dec 31, 2024 | $836.11M | -5.7% |
| FY2023 | Dec 31, 2023 | $886.34M | +40.5% |
| FY2022 | Dec 31, 2022 | $631.00M | -37.6% |
| FY2021 | Dec 31, 2021 | $1.01B | +132.5% |
| FY2020 | Dec 31, 2020 | $435.18M | +100.4% |
| FY2019 | Dec 31, 2019 | $217.17M | -27.8% |
| FY2018 | Dec 31, 2018 | $300.95M | -16.0% |
| FY2017 | Dec 31, 2017 | $358.30M | +245.5% |
| FY2016 | Dec 31, 2016 | $103.70M | +224.7% |
| FY2015 | Dec 31, 2015 | $31.94M | -18.0% |
| FY2014 | Dec 31, 2014 | $38.95M | -16.9% |
| FY2013 | Dec 31, 2013 | $46.86M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.37B | +71.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.37B | +54.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.36B | +59.4% |
| Q4 FY2024 | Dec 31, 2024 | $836.11M | +32.5% |
| Q2 FY2024 | Jun 30, 2024 | $802.45M | -2.9% |
| Q4 FY2023 | Dec 31, 2023 | $886.34M | -12.4% |
| Q2 FY2023 | Jun 30, 2023 | $856.17M | -9.9% |
| Q4 FY2022 | Dec 31, 2022 | $631.00M | +45.0% |
| Q2 FY2022 | Jun 30, 2022 | $826.20M | +194.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.01B | +365.9% |
| Q2 FY2021 | Jun 30, 2021 | $950.45M | +371.5% |
| Q4 FY2020 | Dec 31, 2020 | $435.18M | +83.4% |
| Q2 FY2020 | Jun 30, 2020 | $281.01M | +3.4% |
| Q4 FY2019 | Dec 31, 2019 | $217.17M | -27.8% |
| Q3 FY2019 | Sep 30, 2019 | $201.58M | +74.4% |
| Q2 FY2019 | Jun 30, 2019 | $237.29M | -26.4% |
| Q1 FY2019 | Mar 31, 2019 | $271.86M | +248.1% |
| Q4 FY2018 | Dec 31, 2018 | $300.95M | -16.0% |
| Q3 FY2018 | Sep 30, 2018 | $115.59M | +2.7% |
| Q2 FY2018 | Jun 30, 2018 | $322.49M | +211.0% |
| Q1 FY2018 | Mar 31, 2018 | $78.10M | +2.8% |
| Q4 FY2017 | Dec 31, 2017 | $358.30M | +1021.7% |
| Q2 FY2017 | Jun 30, 2017 | $112.53M | +188.9% |
| Q4 FY2016 | Dec 31, 2016 | $103.70M | +121.3% |
| Q2 FY2016 | Jun 30, 2016 | $75.95M | – |
| Q4 FY2015 | Dec 31, 2015 | $31.94M | – |
| Q4 FY2014 | Dec 31, 2014 | $38.95M | – |
| Q4 FY2013 | Dec 31, 2013 | $46.86M | – |
See a number that looks wrong?